Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-12

Clinical Trial Update: Temozolomide, Nedaplatin, Vincristine, and Radiotherapy as First-line Treatment in Newly Diagnosed Primary CNS Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating temozolomide, nedaplatin, vincristine, and radiotherapy as first-line treatment for newly diagnosed primary central nervous system ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nedaplatin (nedaplatin)
  • Temozolomide (Temozolomide)
  • Vincristine (vincristine)

Snippet

Sponsor: Rongjie Tao | Conditions: Central Nervous System Tumors | Phase 2 | Status: UNKNOWN